Treatment of primary or recurrent non-resectable pancreatic cancer with proton beam irradiation combined with gemcitabine-based chemotherapy

被引：0
|
作者：
S. Lautenschlaeger
C. Dumke
L. Exeli
H. Hauswald
R. Engenhart-Cabillic
F. Eberle
机构：
[1] Universitätsklinikum Marburg,Klinik für Strahlentherapie und Radioonkologie
[2] Marburg Ion-Beam Therapy Center (MIT),RNS Gemeinschaftspraxis
[3] St. Josefs-Hospital,Klinik für Radio
[4] Universitätsklinikum Heidelberg,Onkologie
来源：
Strahlentherapie und Onkologie | 2023年 / 199卷
关键词：
Radioresistant cancer; Salvage chemoradiation; Particle beam radiotherapy; RBE; Gastrointestinal cancers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：982 / 991
页数：9
相关论文
共 50 条
  • [41] A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
    Kanai, Masashi
    Yoshimura, Kenichi
    Asada, Masanori
    Imaizumi, Atsushi
    Suzuki, Chihiro
    Matsumoto, Shigemi
    Nishimura, Takafumi
    Mori, Yukiko
    Masui, Toshihiko
    Kawaguchi, Yoshiya
    Yanagihara, Kazuhiro
    Yazumi, Shujiro
    Chiba, Tsutomu
    Guha, Sushovan
    Aggarwal, Bharat B.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (01) : 157 - 164
  • [42] A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
    Masashi Kanai
    Kenichi Yoshimura
    Masanori Asada
    Atsushi Imaizumi
    Chihiro Suzuki
    Shigemi Matsumoto
    Takafumi Nishimura
    Yukiko Mori
    Toshihiko Masui
    Yoshiya Kawaguchi
    Kazuhiro Yanagihara
    Shujiro Yazumi
    Tsutomu Chiba
    Sushovan Guha
    Bharat B. Aggarwal
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 157 - 164
  • [43] Chemotherapy for patients with non-resectable pancreatic cancer with additional chemo-radiotherapy for patients with potentially resectable tumours: Final Results.
    Pfeiffer, Per
    Ladekarl, Morten
    Mortensen, Michael Bau
    Fromm, Anna-Lene
    Bjerregaard, Jon Kroll
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] Enhanced Antitumor Effect of Combined Gemcitabine and Proton Radiation in the Treatment of Pancreatic Cancer
    Galloway, Nicholas R.
    Aspe, Jonathan R.
    Sellers, Chelsey
    Wall, Nathan R.
    PANCREAS, 2009, 38 (07) : 782 - 790
  • [45] Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data
    Giovinazzo, Francesco
    Soggiu, Fiammetta
    Jang, Jin-Young
    Versteijne, Eva
    van Tienhoven, Geertjan
    van Eijck, Casper H.
    Han, Youngmin
    Choi, Seong Ho
    Kang, Chang Moo
    Zalupski, Mark
    Ahmad, Hasham
    Yentz, Sarah
    Helton, Scott
    Rose, J. Bart
    Takishita, Chie
    Nagakawa, Yuichi
    Abu Hilal, Mohammad
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [46] Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection
    Sahora, K.
    Schindl, M.
    Kuehrer, I.
    Werba, G.
    Fitzal, F.
    Goetzinger, P.
    Gnant, M.
    EUROPEAN SURGERY-ACTA CHIRURGICA AUSTRIACA, 2013, 45 (03): : 169 - 178
  • [47] Inflammatory markers as prognostic indicators in pancreatic cancer patients who underwent gemcitabine-based palliative chemotherapy
    Kim, Hong Jun
    Lee, Suk-Young
    Kim, Dae Sik
    Kang, Eun Joo
    Kim, Jung Sun
    Choi, Yoon Ji
    Oh, Sang Cheul
    Seo, Jae Hong
    Kim, Jun Suk
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2020, 35 (01): : 171 - 184
  • [48] Gemcitabine-based neoadjuvant chemotherapy for locally advanced pancreatic cancer does not affect mortality and morbidity after pancreatic resection
    K. Sahora
    M. Schindl
    I. Kuehrer
    G. Werba
    F. Fitzal
    P. Goetzinger
    M. Gnant
    European Surgery, 2013, 45 : 169 - 178
  • [49] Resected Pancreatic Cancer With N2 Node Involvement Is Refractory to Gemcitabine-Based Adjuvant Chemotherapy
    Liu, Chen
    Cheng, He
    Jin, Kaizhou
    Fan, Zhiyao
    Gong, Yitao
    Qian, Yunzhen
    Deng, Shengming
    Huang, Qiuyi
    Ni, Quanxing
    Yu, Xianjun
    Luo, Guopei
    CANCER CONTROL, 2020, 27 (01)
  • [50] Gene Expression Levels as Predictive Markers of Outcome in Pancreatic Cancer after Gemcitabine-Based Adjuvant Chemotherapy
    Fujita, Hayato
    Ohuchida, Kenoki
    Mizumoto, Kazuhiro
    Itaba, Soichi
    Ito, Tetsuhide
    Nakata, Kohei
    Yu, Jun
    Kayashima, Tadashi
    Souzaki, Ryota
    Tajiri, Tatsuro
    Manabe, Tatsuya
    Ohtsuka, Takao
    Tanaka, Masao
    NEOPLASIA, 2010, 12 (10): : 807 - U161
12345